| Utility: Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Filling date: 6 Sep 2025 Issue date: 23 Aug 2022 | 22 Jun 2020 | 23 Aug 2022 |
| Utility: Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 | 15 May 2019 | 12 Jul 2022 |
| Utility: Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 | 8 Apr 2020 | 7 Jul 2022 |
| Utility: Combination Therapy for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 | 20 Sep 2021 | 30 Jun 2022 |
| Utility: Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 | 3 Dec 2021 | 9 Jun 2022 |
| Utility: FcgammaRIIB-Specific Antibodies and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 | 16 Jul 2021 | 9 Jun 2022 |
| Utility: HER2/neu-Specific Antibodies and Methods of Using Same Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 | 5 May 2021 | 24 Mar 2022 |
| Utility: CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3 Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 | 4 Aug 2021 | 24 Feb 2022 |
| Utility: Covalent diabodies and uses thereof Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 | 5 Sep 2018 | 22 Feb 2022 |
| Utility: Covalent diabodies and uses thereof Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 | 5 Mar 2018 | 22 Feb 2022 |
| Utility: Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 | 14 Jul 2021 | 10 Feb 2022 |
| Utility: Combination Therapy for the Treatment of Cancer Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 | 18 Jun 2021 | 10 Feb 2022 |
| Utility: ADAM9-binding molecules, and methods of use thereof Filling date: 6 Sep 2025 Issue date: 8 Feb 2022 | 21 Dec 2017 | 8 Feb 2022 |
| Utility: Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies Filling date: 6 Sep 2025 Issue date: 23 Dec 2021 | 29 Oct 2019 | 23 Dec 2021 |
| Utility: IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 16 Dec 2021 | 21 Dec 2017 | 16 Dec 2021 |
| Utility: Combination therapy for the treatment of cancer Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 | 6 Oct 2016 | 16 Nov 2021 |
| Utility: CD3-binding molecules capable of binding to human and non-human CD3 Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 | 23 Oct 2018 | 7 Sep 2021 |
| Utility: Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof Filling date: 6 Sep 2025 Issue date: 24 Aug 2021 | 13 Nov 2018 | 24 Aug 2021 |
| Utility: Fc.gamma.RIIB-specific antibodies and methods of use thereof Filling date: 6 Sep 2025 Issue date: 24 Aug 2021 | 6 Sep 2018 | 24 Aug 2021 |
| Utility: Optimized gp41-Binding Molecules and Uses Thereof Filling date: 6 Sep 2025 Issue date: 12 Aug 2021 | 13 May 2019 | 12 Aug 2021 |
| Utility: Combination therapy for the treatment of cancer Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 | 9 Jun 2016 | 3 Aug 2021 |
| Utility: LAG-3-binding molecules and methods of use thereof Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 | 7 Jun 2016 | 27 Jul 2021 |
| Utility: LAG-3-Binding Molecules and Methods of Use Thereof Filling date: 6 Sep 2025 Issue date: 8 Jul 2021 | 12 Jan 2021 | 8 Jul 2021 |
| Utility: NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 | 17 Dec 2020 | 10 Jun 2021 |
| Utility: Bispecific CD16-Binding Molecules and Their Use in the Treatment of Disease Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 | 6 Dec 2018 | 10 Jun 2021 |
| Utility: HER2/neu-specific antibodies and methods of using same Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 | 10 Oct 2018 | 8 Jun 2021 |
| Utility: Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease Filling date: 6 Sep 2025 Issue date: 27 May 2021 | 13 Feb 2019 | 27 May 2021 |
| Utility: METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4 Filling date: 6 Sep 2025 Issue date: 6 May 2021 | 13 Jan 2021 | 6 May 2021 |
| Utility: COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 15 Apr 2021 | 22 Oct 2020 | 15 Apr 2021 |
| Utility: Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 | 22 Jun 2020 | 1 Apr 2021 |
| Utility: B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof Filling date: 6 Sep 2025 Issue date: 30 Mar 2021 | 13 Apr 2017 | 30 Mar 2021 |
| Utility: Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 | 12 Dec 2016 | 23 Mar 2021 |
| Utility: Dosing Regiments of Bi-Specific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies Filling date: 6 Sep 2025 Issue date: 4 Mar 2021 | 7 Sep 2017 | 4 Mar 2021 |
| Utility: COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 25 Feb 2021 | 26 Aug 2020 | 25 Feb 2021 |
| Utility: Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof Filling date: 6 Sep 2025 Issue date: 18 Feb 2021 | 24 Aug 2020 | 18 Feb 2021 |
| Utility: Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting Filling date: 6 Sep 2025 Issue date: 17 Dec 2020 | 29 May 2020 | 17 Dec 2020 |
| Utility: Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof Filling date: 6 Sep 2025 Issue date: 8 Dec 2020 | 21 Nov 2017 | 8 Dec 2020 |
| Utility: Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof Filling date: 6 Sep 2025 Issue date: 3 Dec 2020 | 7 May 2020 | 3 Dec 2020 |
| Utility: Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof Filling date: 6 Sep 2025 Issue date: 24 Nov 2020 | 18 Feb 2019 | 24 Nov 2020 |
| Utility: BISPECIFIC MOLECULES COMPRISING AN HIV-1 ENVELOPE TARGETING ARM Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 | 2 Jun 2020 | 12 Nov 2020 |
| Utility: Compound targeting IL-23A and TNF-alpha and uses thereof Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 | 1 Aug 2018 | 6 Oct 2020 |
| Utility: Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 | 12 Oct 2017 | 29 Sep 2020 |
| Utility: COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 13 Aug 2020 | 6 Jun 2017 | 13 Aug 2020 |
| Utility: Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 | 24 Jan 2018 | 4 Aug 2020 |
| Utility: Antibodies reactive with B7-H3 and users thereof Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 | 4 Jan 2018 | 4 Aug 2020 |
| Utility: PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 | 24 Jan 2020 | 23 Jul 2020 |
| Utility: Bispecific molecules comprising an HIV-1 envelope targeting arm Filling date: 6 Sep 2025 Issue date: 21 Jul 2020 | 29 Sep 2015 | 21 Jul 2020 |
| Utility: Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting Filling date: 6 Sep 2025 Issue date: 14 Jul 2020 | 13 Jun 2017 | 14 Jul 2020 |
| Utility: Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof Filling date: 6 Sep 2025 Issue date: 9 Jul 2020 | 3 Mar 2020 | 9 Jul 2020 |
| Utility: MULTI-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS Filling date: 6 Sep 2025 Issue date: 2 Jul 2020 | 13 Mar 2020 | 2 Jul 2020 |
